1 Min Read
Sept 13 (Reuters) - NEWRON PHARMACEUTICALS SPA:
* H1 NET LOSS OF EUR 7.6 MILLION VERSUS PROFIT OF EUR 1.6 MILLION H1 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.